Chaoyong Shen1, Luyin Han2, Baike Liu1, Guixiang Zhang1, Zhaolun Cai1, Xiaonan Yin1, Yuan Yin1, Zhixin Chen1, Bo Zhang3. 1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. 2. Intensive care unit, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. 3. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. hxwcwk@126.com.
Abstract
BACKGROUND: It is urgent to explore the pathogenic mechanism of gastrointestinal stromal tumours (GISTs). KDM6A, a histone demethylase, can activate gene transcription and has not been reported in GISTs. SPARCL1 may serve as a metastasis marker in GIST, but the molecular mechanism remains to be further explored. This study aimed to explore the biological function and molecular mechanism of KDM6A and SPARCL1 in GIST. METHODS: CCK-8, live cell count, colony formation, wound-healing and Transwell migration and invasion assays were employed to detect the cell proliferation, migration and invasion. A xenograft model and hepatic metastasis model were used to assess the role of KDM6A and SPARCL1 in vivo. RESULTS: KDM6A inhibited the proliferation, migration and invasion of GIST cells. Mechanistically, KDM6A promotes the transcription of SPARCL1 by demethylating histone H3 lysine trimethylation and consequently leads to the inactivation of p65. SPARCL1 affected the metastasis of GIST cells in a mesenchymal-epithelial transition- and matrix-metalloproteinase-dependent manner. SPARCL1 knockdown promoted angiogenesis, M2 polarisation and macrophage recruitment by inhibiting the phosphorylation of p65. Moreover, KDM6A and SPARCL1 inhibited hepatic metastasis and macrophage infiltration in vivo. CONCLUSIONS: Our findings establish the critical role of the KDM6A-SPARCL1-p65 axis in restraining the malignancy of GIST.
BACKGROUND: It is urgent to explore the pathogenic mechanism of gastrointestinal stromal tumours (GISTs). KDM6A, a histone demethylase, can activate gene transcription and has not been reported in GISTs. SPARCL1 may serve as a metastasis marker in GIST, but the molecular mechanism remains to be further explored. This study aimed to explore the biological function and molecular mechanism of KDM6A and SPARCL1 in GIST. METHODS: CCK-8, live cell count, colony formation, wound-healing and Transwell migration and invasion assays were employed to detect the cell proliferation, migration and invasion. A xenograft model and hepatic metastasis model were used to assess the role of KDM6A and SPARCL1 in vivo. RESULTS: KDM6A inhibited the proliferation, migration and invasion of GIST cells. Mechanistically, KDM6A promotes the transcription of SPARCL1 by demethylating histone H3 lysine trimethylation and consequently leads to the inactivation of p65. SPARCL1 affected the metastasis of GIST cells in a mesenchymal-epithelial transition- and matrix-metalloproteinase-dependent manner. SPARCL1 knockdown promoted angiogenesis, M2 polarisation and macrophage recruitment by inhibiting the phosphorylation of p65. Moreover, KDM6A and SPARCL1 inhibited hepatic metastasis and macrophage infiltration in vivo. CONCLUSIONS: Our findings establish the critical role of the KDM6A-SPARCL1-p65 axis in restraining the malignancy of GIST.
Authors: Bayan Al-Share; Abdulrahman Alloghbi; Mohammed Najeeb Al Hallak; Hafiz Uddin; Asfar Azmi; Ramzi M Mohammad; Steve H Kim; Anthony F Shields; Philip A Philip Journal: Cancer Metastasis Rev Date: 2021-04-19 Impact factor: 9.264
Authors: Brian P Rubin; Charles D Blanke; George D Demetri; Ronald P Dematteo; Christopher D M Fletcher; John R Goldblum; Jerzy Lasota; Alexander Lazar; Robert G Maki; Markku Miettinen; Amy Noffsinger; Mary Kay Washington; Thomas Krausz Journal: Arch Pathol Lab Med Date: 2010-02 Impact factor: 5.534
Authors: G Xie; X Liu; Y Zhang; W Li; S Liu; Z Chen; B Xu; J Yang; L He; Z Zhang; T Jin; X Yi; L Sun; Y Shang; J Liang Journal: Oncogene Date: 2017-05-22 Impact factor: 9.867
Authors: Joni Van der Meulen; Viraj Sanghvi; Konstantinos Mavrakis; Kaat Durinck; Fang Fang; Filip Matthijssens; Pieter Rondou; Monica Rosen; Tim Pieters; Peter Vandenberghe; Eric Delabesse; Tim Lammens; Barbara De Moerloose; Björn Menten; Nadine Van Roy; Bruno Verhasselt; Bruce Poppe; Yves Benoit; Tom Taghon; Ari M Melnick; Frank Speleman; Hans-Guido Wendel; Pieter Van Vlierberghe Journal: Blood Date: 2014-10-15 Impact factor: 22.113